Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
PsyDAO Community Town Hall ✨🍄
Recorded: Aug. 10, 2022 Duration: 1:02:10Space Recording
Full Transcription
Hey, hey.
Thanks for joining the premier Psydow Community Town Hall.
Nice to see you, Michael.
Just give a couple minutes here while people filter in.
Nice to see you.
Nice to see you.
All right.
All right.
All right.
Thank you, everyone, for being here.
And great to see everyone.
We've been really excited at PsyDAO as we've been putting some of the initial pieces in place for formally launching the DAO.
I'll give a little bit of background.
PsyDAO was soft launched and kind of given birth last fall in Lisbon and really kind of spun out of all the momentum around Molecule and the bio XYZ ecosystem.
In fact, Molecule is really incubating.
And we are one of the first cohort of companies going through the bio XYZ ecosystem and have received 100K grant from Molecule.
So super happy that they're here.
And we also have Theo is also joining us.
Theo, you want to say hello?
Yeah, thanks, Matt.
Hey, hey, guys.
Nice to be here.
It's spontaneous.
But, yeah, I'm also working at Molecule in the marketing working group department and just having also SIDO setting everything up.
And, yeah, it's getting excited.
We are seeing this for quite some time now, building up slowly to a point where we have the first community call now today.
So I'm super excited.
And, yeah, thanks, Matt, for pushing this group for the first time.
Yeah, of course.
Of course, Theo.
So we have a bit of a smaller group here.
And I don't want to put too many of you on the spot.
But we're really curious who's joining today, what drew them to PsyDAO.
And if there's anything else they want to share.
We are recording this, so do keep that in mind if you, you know, would rather stay anonymous.
So if anyone feels motivated or interested, you can kind of, I think, request to be a speaker.
I can invite you up on stage.
Again, no pressure.
And if you don't feel like being put on the spot, no sweat.
But I do want to make sure that you know that the invitation is there to kind of share what brings you here today and why you're inspired by PsyDAO.
So I'll let you kind of think on that.
And in the meantime, I want to just kind of cover a couple things.
You can see this in our Discord.
But I think it'd be great just to kind of talk about a couple things that are underway.
Let's see here.
Nice.
Okay.
The launch of our website is imminent.
So we're just putting kind of like the final touches.
We'll be launching that.
We'll be certainly announcing that here on Twitter as well as putting an update into the general announcement channels on our Discord instance.
So keep an eye out for that.
We also have that's built into the website.
We have a fantastic video that really speaks to why PsyDAO and our mission to keep psychedelics unmonopolizable.
Or we often like to say, as we know, we're building the Gitcoin for psychedelics, right?
So we're right at this intersection, this juicy intersection of decentralized science, Web3, and psychedelics.
And in terms of other things to share, along with the website and the launch of our video,
is that we're currently applying for the Seed Club Accelerator.
For those of you who don't know, Seed Club, the Seed Club Accelerator is one of the more well-known accelerators in the Web3 space
that really are just launching a lot of innovative and progressive community DAOs.
And we think it'll be a long-term strategic advantage to being part of this community
because they're very much vibes and values aligned and helping us do our best to make psychedelics unmonopolizable
and get into the things that we're working through now, right?
Like writing the light paper, figuring out the tokenomics, the governance, figuring out what fundraising looks like
and how to do that in a way that's transparent, that's equitable, that serves the greater good.
And so, yeah, if you happen to be a club token holder, you can actually view our application.
You can comment on it. You can boost it.
There's some tweets in our stream that have all the info there.
It's also posted in the announcement channel.
So do check that out if you'd like to learn more about what we're doing.
We should find out in the next weeks if we make it into the Seed Club SC05 cohort.
So there's that.
And I kind of touched on a few other things, right?
So we're spinning up our working groups on governance, awareness, sorting through the tokenomics.
Also, we have the operations working group up and running, putting in all the basics, you know, email, all the systems.
We're also putting in the kind of the Web3 foundational kind of DAO stack type stuff.
So we are spinning up our bounties on Dwork.
We are also starting to utilize Clarity in terms of having a basically a Web3 version of Notion and task management.
And what else what else to say?
Let me take a pause there and just welcome the others who have joined the call.
And and please, if you have anything you want to comment on or if you'd like to ask a question, please throw your hand up.
A request to to be a speaker and happy to have you on the stage.
All right.
I'm going to take silence as consensus here and just keep on going.
You can also make comments if you like, if you prefer not to speak.
Other news.
So we've reserved.
We've received our first block, our first tranche of funding from Molecule.
So we have 33,000 USDC has been put into our multi-sig.
And so that is set up.
We will I think we're in the process of pointing our ENS address that should be pointing there to the multi-sig soon.
We'll make an announcement about that.
So we have cydao.eth.
That's also being put into the works.
And I think probably for this group, everyone's probably wondering, like, when are you going to launch the first projects?
So we're in the process of kind of assessing and vetting various projects, if you want to think of it as from a deal flow perspective of what kind of research projects do we think would be like the right size, as well as the right fit for basically if you want to think of it as like season zero or season one for the first tranche of research projects.
We don't have any fixed announcement or timeline on that yet, but do stay tuned.
We will be making some announcements about the first projects in the coming weeks.
Theo, have I missed anything in terms of general announcements?
Back from my side, like, what maybe I would like to say is just, yeah, drop in into the Discord.
We are looking for talented people for all the working groups, obviously.
And I think that's, it's just the beginning of something very new and the second BioDAO ever launching after VitaDAO last year.
So I'm just super excited about, like, how everybody's coming together in Discord.
And we also have a, with Adam, who's unfortunately not able to join today for the community call, who is the lead steward of CIDAO.
And, like, the stuff, what's happening behind the scenes is just, yeah, it's just great to see that this, like, slowly turns out into a real project.
And, like, I know, like, Steve is also on the call, and we are talking about this for a few months now.
And, yeah, really happy to see this coming to life.
And, yeah, not the biggest stage experience guy, but let's get Consigli.
I can't read the full name here on the stage.
So if you have any question or input, please share it with us.
Hello. Can you guys hear me?
Yeah, we hear you. We hear you great.
Yeah, thanks for throwing your hand up and joining us on the stage.
Yeah, no worries.
I'm Gavin. Hi, everyone.
I'm from Singapore.
So psychedelics is kind of taboo in my country, but I'm a longevity and anti-aging enthusiast.
And that's what led me to contribute to VitaDAO in the governance working group.
And, really, I've always been on a mission to attain self-transcendence, master the mind, really, and just revolutionize healthcare.
So I'm really, really curious and really excited about PsyDAO and always have been in what the intersections of longevity and psychedelics could, you know, could show.
And I'm really happy to contribute in any way to any working group.
And, really, really what my question was, what is the moonshot vision for PsyDAO?
Really interested in what started the incubation of the idea?
Yeah.
Sure.
Well, I can, yeah.
First of all, I have to say I really love your name, Consigliere.
It's really, it's a really fantastic, fantastic name, handle for yourself.
And, yeah, I mean, I also, I'll just give a little bit of context here.
I'm originally from Detroit.
I'm from the Midwest of the States and now live in Berlin.
And I think growing up, I think, yeah, there was a, psychedelics were a little bit taboo and, you know, maybe something you kind of, you know, ventured with a little bit, but you didn't take too seriously or too much into adulthood.
And I think it definitely wasn't looked at as like a path of personal growth and development, which I very much now think it is that psychedelics can be a practice and can certainly be a big accelerant to personal insight, personal growth, personal development on all different facets of your life, you know, personally, professionally, in your, in your close friendships, in your, in your deepest relationships.
In terms of the, in terms of the, in terms of the moon, the moonshot vision, you know, you know, I was not one, you know, there at the, the genesis of, of, of, of PsyDOW.
I've been active since DCI Berlin, when I got back to Berlin after some extended travels in, in Sri Lanka.
But I would say in terms of like, what I've gathered is, is that, you know, now as psychedelics go mainstream, there's been this huge push to, which in some aspects is good to, to commercialize and mainstream psychedelics.
But there's also been something that is, um, um, um, um, um, not so good about that, which is, I think there's just been this push to aggressively do a land grab on the IP for psychedelics.
And to, um, um, I think the worst case scenario is that they become, you know, um, put into formats that people would need to have prescriptions for, for the rest of their lives.
Like we've seen with SSRIs and other things, um, and to kind of go down this, um, go down this route, um, that doesn't really serve, um, the greater growth and expansion.
Um, or if you want to go as far as like self-actualization, self-realization of people to really expand consciousness and, and to reach and become their, their, their greatest version of themselves.
Right.
Um, and I think the medical model, uh, which is looking at just to kind of like keep people at a well-adjusted mediocrity, um, or even some of the pushes I think to, oh, can we get the benefits of psychedelics without having a life transforming psychedelic experience?
For instance, there's been talk of that.
Um, and I, and so, um, for me, I guess I put it in my own words, uh, rather not necessarily speak for the everyone else.
I think everyone else in the side out team probably has their own little bit of their own version of the moonshot right now, um, is to make sure that, um, people have broad access to the most transformative, uh, and life changing, um, and life affirming, um, aspects of psychedelics.
Um, and they can make their own choices, um, and they can make their own choices for that.
And we're not just kind of confined to a, um, a very, um, capitalistic or, um, um, market driven or medical model, even medical model driven, uh, relationship with psychedelics.
Um, I would say that's the bigger, the bigger vision.
I don't know, um, Theo, if you have anything else you'd like to, to add to that.
Um, yeah, that's, that sounds, uh, can you hear me?
Yeah.
Yeah.
We can hear you.
Okay.
Perfect.
Um, no, it sounds, it sounds amazing.
And, uh, thanks for the question.
Um, for me, like personally, if you would ask me like one year ago, uh, I wasn't really experienced with like psychedelics at all.
Like that was just something for me where I said, like, it's a forbidden drug.
You should, you shouldn't take it.
Um, and I learned over the past year that this can have a massive, just impact on mental health and that pharma is, you know, um, they are obviously looking for, for ways to make a profit, but to, to have a, like one shot therapy.
Um, which, uh, which, uh, which sometimes has like a 50, 60, 70, 80% success rates depends on, on, on, on the cure.
Obviously like, is it, um, depression?
Is it like something like addiction?
And I learned that this can, yeah, just open your mind and that, uh, it, it can help a lot, um, if you compare it to like other depression drugs or something like this.
So for, for me as a marketer and, uh, the longterm thinking in my case is just to educate people around, um, the possibilities and the power of this, of this drug.
That it, it's something when you take it in a safe, like, uh, experience with a therapist, it's something which can help you a lot.
And with family, which is struggling with depression for, for like a long time, my grandma, uh, since, since she was 40 and my, my, my, my mom with the same.
Um, and to bring something like this to the masses, like just the, the possibility is still something like in Germany, uh, which is far, far away from, from reality.
So like, that's something why I, I want to contribute to side out and to, to, to help bring this project to life.
And I also listened to podcasts that there are financial struggles, uh, because even projects who are backed by the DEA, um, are getting blocked, uh, with financial, uh, like by the bank, uh, because like they, they do psychedelic research.
Um, there are IP issues, uh, with this.
So, um, I think we have a lot of work to do and I, I just want to like, from my side, I, I just want to help from a marketing side as much as I can to just educate really around this, this topic.
Because I, I remember like a good friend showed me a graph, like there was, um, like all the drugs you can consume on like alcohol and, uh, cigarettes and, you know, all that stuff.
And, uh, psychedelics is just one of the most, like least impactful, like from the harmful side.
So, um, yeah, it's just something you need to learn.
So that's something why I am, uh, hyped about side out and that's my moonshot to educate people.
Yeah, that's, that's awesome.
Cheers for that.
And, and yeah, I think education is the key part.
It's almost like we have to change the mindsets, um, away from the taboo of it all to see the benefits health wise and very much in line with what I try to do, um, with my life.
I mean, my, my, my moonshot for myself is to master the mind and to attain that self-transcendence and side out.
I think it's a perfect place to start.
And, and yeah, I mean, sounds like you guys are in great hands and, um, happy to help, happy to be part of these awesome, this awesome community too.
So, um, yeah, cheers for that.
Yeah.
Thank you for, uh, yeah, for sharing, sharing what your experience is and why you're inspired to, to get involved.
Would anyone else, uh, uh, like to, uh, step on the stage, ask a question, uh, share their experience?
I'll let you, let you think on it.
Um, so we mentioned, uh, a few things for those who, I think some new people have, uh, come on, other people have peeled off.
So, um, I guess I should introduce myself because I realized I'm actually on the side out, um, Twitter handle, like this is, uh, Matt DeCausen.
I'm on, uh, my, my title is the, uh, unofficial chief of staff, um, at side out, um, on the core team.
Um, and, um, let's see here.
Let's see a request.
One second.
There you go.
Um, and, uh, yeah.
So those of you want to connect with me, you can find me there.
I'm happy to, uh, have everyone here.
Um, and, uh, yeah, in terms of like, uh, those who just joining in.
So, um, we've got our first tranche of the grant from Molecule.
We've applied for the Seed Club Accelerator.
Um, the, the multi-sig is set up.
Uh, we're connecting our, uh, side out.eth, um, ENS now and having that point there shortly.
Um, so you want to send your millions there.
Um, and, um, we're, as, uh, Theo mentioned earlier, um, we're really trying to scale things up, uh, starting to scale things up.
I should say, um, build out the, uh, the different working groups, uh, get everyone kind of, uh, up to speed on, uh, Dwork and Clarity, which are our DAO stack tools that we're using.
Um, so if you go into the Discord and you look at the, um, about channel or in the announcements, you'll see that there is a link to get involved, which, uh, puts you over to an air table.
Um, and you can kind of say, like, this is how much time I got.
This is what I'm most jazzed about doing.
Um, these are my, these are my superpowers, et cetera.
Uh, so we'd love to get you involved, um, if you are keen to do so.
Uh, there is plenty to do.
Um, and, yeah, um, and I want to, uh, recognize that, um, I am, I am that omen, uh, just, uh, came up on the stage.
Uh, welcome.
Hey, guys.
Thanks.
Thanks for having me.
Um, I must say I'm pretty excited.
Uh, I just, uh, recently found out about, uh, PsyDOW and, uh, it got me thinking about a lot of the things that I, uh, in the recent years I started thinking about.
How, you know, making, uh, psychedelics more, uh, uh, well-known and, uh, over their good qualities.
And I got to experience the therapeutic effects of psychedelics, uh, early on.
Um, and it really, it really helped me.
Um, and, you know, I just, I just want to raise, you know, a question that I have in mind, uh, about, you know, what we're planning to do here.
Um, like, obviously we can take this, um, you know, this movement, the DAO, uh, into, you know, different directions.
We can, uh, work on the educational side.
We can work on the regulation side on the, um, you know, supporting researchers and, uh, investing in, in, in psychedelic, uh, projects.
And for me, I mean, uh, what I would like to, to understand and, and probably we don't, we don't, I don't know if you guys understand it already, but, uh, what I would like to understand is what we are aiming to do here, to achieve here.
Um, and, and, and how can we achieve that in the, in the best way possible?
Um, and in order to, you know, to, to promote, um, medical research and, and to promote, you know, uh, everything that, that, that you guys said before.
So, uh, yeah, I think that's, that's the question that I, that I have in mind.
Like what, what are our goals here and, you know, and, and what is the path that we see forward?
And maybe, maybe you covered that in the, in the, in the, before I joined, I don't know, but.
No, no, that's a great question.
We had, uh, earlier consigliere was asking, you know, what's the, uh, what's the moonshot?
And I think actually the moonshot vision, um, and I want to recognize that, um, Adam Goyer, um, who is, um, uh, the lead steward on, uh, on first, first side out, uh, just.
Uh, just joined us.
Welcome Adam.
And I think this is a great chance for Adam to share his, uh, moonshot vision for, for side out.
Oh man.
Uh, mostly just faking it till I make it.
So, uh, hope it all works out for everybody.
Uh, no, in all seriousness, really trying to be a steward of, of what is, I see as a pent up energy.
Uh, you know, there's a lot of goodwill for, uh, psychedelics brewing and has been brewing and fermenting in the underground.
For what, five decades now.
So, you know, I think the, we seem to be at this unique moment in time where, you know, the, this.
Okay.
Sound check.
I got check.
I can hear you.
Okay.
Sorry.
I'm not sure what happened there.
I think we want to figure out, you know, what do we want to build?
What do we want it to look like?
There's, you know, there's the medical model in the West, which I think has, you know, failed a lot of people.
The decriminalization model seems like an appropriate foundation, like don't put people in jail.
Kind of seems like a no-brainer.
And then we've got to figure out, you know, but what does it look like to grow into the space?
You know, what does the growth hierarchy look like here?
Where, you know, we're kind of, you know, building upon, you know, the wisdom and the knowledge that's already been established, leaning into decentralization, leaning into censorship resistance.
You know, the joke I keep leaning into is, you know, build a library of Alexandria that won't burn.
You know, distribute the information and the knowledge and the wisdom very widely.
You know, make many copies of the data.
You know, so you look at the entire, kind of the entire stack, you know, from citizen science and kind of self, you know, self-tracking all the way up to, you know,
You could, you know, you know, potentially in decades get to distributed production, you know, and also build, you know, tools for, you know, ayahuasca churches to communicate and organize.
There's all kinds of things and concepts that need to be developed because it's been suppressed for so long.
So I think what we're leaning into as a concept is something akin to Gitcoins for psychedelics, you know, building mechanisms to see, to find the signal among the noise, get those projects funded, help them get organized.
And I think that's probably a pretty good place to start that, that, you know, that probably starts allowing a community to come together.
It has kind of a relatively clear, concise, you know, thing that we can all kind of coalesce around, but it also allows for a wide breadth and swath of different things to be, to, to come together.
If that makes sense.
Matt, maybe help me out with a, with a, with a closing thought there.
I think I got a little confusing at the end there.
No, I mean, I think you, you covered it, you know, this idea of, of, of broadening out, you know, broadening out access and, and making sure that the science and the, the, the research in terms like what's the, what's the social,
what's the social and, and, and personal and transformational value of these molecules of, of these, of these medicines, of these substances are not just monopolized in these constellations of, of power of market forces of, of, of, you know,
I was just stunned, you know, reading about how, you know, just listening to Rick Doblin speak during the, the, the Michael Pollan series on Netflix about how, you know,
he wasn't sure if he would have gone down this road, if he would have known it would take a hundred million dollars to blaze the path they've had to blaze for MDMA.
And I think ultimately the, the vision for PsyDOW is like, how can we be, you know,
decentralize the research and be more agile and come up with novel ways of, of proving out the social value and coming up with innovative, of ways of, of, of accessing these,
these molecules, these medicines in a way that best, that serves the greatest good.
um, I, I think that's, uh, the way I think of it and we don't have, obviously these are early days.
We don't have all the answers and I think there's going to be a lot of, um, you know,
that's why we're assessing, looking at a, a broad swath of, of different types of, uh, of research projects of, of, uh, different scopes, different approaches.
And maybe this is a nice, uh, segue, um, Adam, I kind of teased people earlier and said, you know, we're, you know,
we haven't launched any projects yet. We're vetting them. We're kind of figuring out our strategy.
We're putting a lot of the operational, uh, you know, kind of foundational pieces in place in terms of working groups, D work, clarity,
the multi-sig is set up. We're applying for seed club accelerator. We're, you know, you know, getting all these pieces in so we can kind of really, um,
move forward and have like the new websites out and people can really resonate with the message and find pathways to participate and bring their skills
to bear. Um, but maybe since we're talking about the, the, you know,
the specific ways of kind of engaging in this work, um, since you've been much more on the front end of that,
do you want to say a bit about your view on the, on the,
the research projects and where we are in that and, and, um,
how you think we want to kick off season zero or season one, whatever we're calling it?
Yeah. I mean, just, so just to kind of test the waters a little bit, there's a,
there's a company, a foundation, the entheogen foundation,
their stated, their stated mission is to, um,
is to sequence all of the world's genetics, uh, for entheogens. So all of the world's,
you know, magic psilocybin producing mushrooms, um, you know,
and then we'll move on to the plants,
which are orders of magnitude more difficult from a gene sequencing perspective.
And we're talking about how to store all this information, you know,
collaboratively on the blockchain and, uh, you know, kind of a, and again,
in a censorship, censorship resistant way, how to, you know,
they're basically already running a decentralized platform because these things
grow all over the world. So they have to send people physically out into the field.
You know, they have to have a, they have to get that to a,
to a gene sequencing lab, um, lab doubt is assisting with the protocol for that.
Um, so, so it's, it's a, it's a, it's a, I think it's an early indicator of
what decentralized science can look like in psychedelics. Um,
this one is like super safe and super easy, right? It doesn't, it doesn't, um,
it doesn't bother anybody for like a cultural level, like, Oh,
gene sequencing plants, but what do we care? You know, spores, no one,
no one's bothered by that. Um, but, you know, laying a foundation here,
I think makes for some good primitives on where this can all,
all go as we start to start to lean into these concepts.
Fantastic. Uh, thank you, Adam, for kind of like the,
the high level view there on the, on the research projects. Um,
any questions, uh, about the, uh, about the research projects, anyone, uh,
or any of the kind of announcements we've made so far, um, let me know,
throw your hand up if you like, I'll, I'll bring you to the stage. Um,
um, and, uh,
go ahead.
Just a couple of things that why we're, you know, it's a,
it's a pretty small group here, but we are, um, we're starting to look,
look for and identify working group,
working group stewards for the different working groups. Um,
we hope to have a, you know,
a proposal page up relatively soon for, um, for,
for proposals we're drafting the, once we have the governance in place,
we'll, you know, we'll start like we're trying to get kind of the mechanisms
in place to run all of this. Um,
but I think relatively swiftly here we'll be able in a position to start
accepting proposals and, and start building. So, um, you know,
if people have interesting projects or research that they would like to,
you know, think would be a fit, but let's,
let's have a conversation about it.
Um, yeah, that's a great point. And then, um, if you,
if you look at our announcements, um, channel in discord, um,
you can also certainly ping us on, uh, on Twitter. Um,
there is a link, um, in there to, uh,
to Adam's, um, calendar.
If you wanted to request like an informational kind of just meet and greet,
share an idea, you can do that as well. Um,
and then obviously we'll be hosting these, uh,
community town halls every other Wednesday, same,
same bat time, same bat channel. Um, and, um,
another, uh, live update I'd like to share, uh,
just going back and forth with, uh, our, our team and, um,
the DNS settings are getting updated right now. And, uh,
so the launch of the new website is imminent. Um,
so we will certainly be putting that out into the announcement and general
channel and tweeting about it. Uh, and, uh,
we're looking forward to the community having access to the website and,
and let us know what you think.
Anyone else, uh,
anyone else like to, uh, come on stage, ask a question,
share a story about psychedelics, uh,
con con sigil. I know that you've been active in our discords.
Why don't you put some time on the, on my, on calendar and we'll,
we'll connect looking forward to chatting with you about,
about what could come next.
I think he's got the creative, uh, consigliere, uh, title there, uh,
like in the, uh, you know, um, uh, you know what I mean?
You know what I mean? The consigliere, man, you're the consigliere.
All right. So, um,
I think, you know, we got another, you know, 20 minutes was on the schedule.
We don't have to use all that time. Um,
I think we've covered, uh, most of the announcements, uh, we're doing,
we'll be doing more of this. Um, please do, um, you know,
give us a shout on the discord or on Twitter. Um, Oh,
I see someone, uh, jumping in here to get on the stage.
Come on up.
Hello. Hello.
Hi guys. Um, I'm staying anonymous, but I'm reflection on Twitter,
an avid underground psychedelic user for 20 years.
I actually don't use any substances anymore,
but I am a big proponent of psychedelics and they changed my life.
And the biggest thing I fear with this movement with maps and, um,
other places like field trip and is that they're going to require people to use a
guide. And that gets a little dicey when you're putting the power in someone
else's hands, the people taking them might miss the point.
The point is it's all you.
So they're going into it almost thinking that these therapists are above them and
look, you know, looking to them. And that just worries me.
It seems like it could be a recipe for disaster. For example,
I listened to, um, uh,
shoot that series. There was a series by New York.
It was called, I'm sorry,
I'm drawing a blank,
but it was a podcast where some of the maps participants,
you know,
were sexually assaulted or had,
had these horrible experiences that maps didn't even detail.
And they were suicidal and whatnot. So I worry that,
you know,
it's only going to be in the hands of therapy in the United States.
And I really am looking to get involved with people that want to make it
decriminalized. So, you know,
if you want to go to a therapist for it, great.
But if you just want to take it yourself and you have a friend there as a guide
or whatever, or just, you know,
a lot of my trips were by myself,
um, that that should be available too.
So I'm just looking to get with some people in a community to push for that
because that's the most important to me.
Yeah. I think we're, we're highly values aligned with the,
with the decriminalization side of things. Uh, you know, I love,
I love the work that maps has been doing and we would,
we certainly would not be here, like having this, you know,
open conversation on Twitter, if not for, you know,
kind of Doblin and crew carrying the torch to the psychedelic winner for,
you know, 50 plus years. Um, but, but also, yes, you know,
and I think if you really,
if you kind of got Doblin outside of his role as leader of maps,
he would probably say the same thing. Um, you know, he's,
they've been doing as a group and doing work on harm reduction and whatnot for a
long, long time. You know,
and I think what maps has done is,
is revealed the difficulties of the medical path.
Um, you know,
trying to do a medical path for all of these different molecules would cost
billions of dollars and decades of more time that I think our culture really
can't afford to, you know, waste. Um,
for me personally, you know, I think I've told the story, you know,
many times my, my first psychedelic experience was, you know,
on the top of a mountain with a friend, you know,
and the mountain had just been kind of burned out by fire. And it was,
it was, you know,
kind of terrible in its, in the setting, but also it was kind of,
you know, exactly what I needed. Um,
there's no way I would have had that kind of experience in a clinic. Uh,
similarly, my first experience with,
with MDMA was at a music festival and, you know,
is that lightning in a bottle and there's that bridge that you walk across if,
if for anyone who's been there, um,
it's like this suspension bridge, but over this goalie. And like,
it's this two way, you know,
pretty narrow bridge and people high five each other as they go down it.
And I was like young and grumpy. And I'm like, why are these people high-fiving
each other? It seems weird to me. And then I took,
took MDMA and I walked across the bridge and all of a sudden I was like happy and
light. And I was high-fiving people. And I was like, Oh,
I didn't know I could be this person. Right. Um,
I didn't know I could be kind of happy and open and like between those
experiences, it kind of shifted the course of my life in a way that,
uh, yeah, I just doing that in a clinic would have been different.
It would have had different outcomes. Um, so I,
do I think clinical work is important? Yes.
If your person has severe PTSD, you know, or, and,
or other, other ailments, like,
are there people that should probably prioritize work in a clinic? Yes.
Like you're doing really, really deep shadow work or, or something, you know,
like, you know, trying to kind of clear out trauma,
all this stuff can be, can be really overwhelming. And it's,
can be beneficial for a person to work with somebody on these things. Um,
but certainly all of us, you know,
almost all of us who are currently involved in the,
in the work with psychedelics, you know,
our first many experiences were, uh,
underground by definition. Right. And,
and it had such an impact on us that we're like, you know,
dedicating a significant portion of our life to this work. So, um,
yeah.
Yeah. Um, just to, uh, you know, second, what, uh,
what Adam had to share. Um, yeah,
all of my major, um,
like first encounters with psychedelics, um,
the majority of them really have all been, um, underground. Um,
and while I did my best, I find it kind of like that the set and setting,
I think would really work well. Um, yeah,
many of them were with underground guides and we're not, uh, you know,
these legally sanctioned or, um,
confined to the medical model and, uh,
would agree that maybe there's a certain, uh, you know,
you know, uh, treatment resistant PTSD. Um, there are certain,
there are certain situations where, yeah, um,
having more of a medical model,
having that kind of container could be the best thing. Um,
but I certainly, and I think, you know,
from a values perspective and a vision perspective that we would not want that
to be the only available way of, uh,
experiencing psychedelics. I think that, um,
that, uh, while there,
it's important that there's to recognize the people that are, um,
suffering from substance, um, abuse issues or addiction issues,
trauma, depression, um,
that not all of them are going to fit within the, you know,
the, the medical model treatment scenario. Um,
and then also even beyond that,
there's also this concept of the betterment of the well, right?
That you don't have to be dysfunctional or have a, you know, um, uh,
fit into some neat kind of medically defined, uh,
symptom or category to have a relate,
a meaningful relationship or meaningful psychedelic practice,
um, that is hugely beneficial for yourself, um,
the planet and, um, all your relations.
I think that's a really important point.
Yeah. I mean, if, if, if I could dream a little bit,
I would love to envision a world where, you know,
side out was something of a kind of a self regulatory agency where we were kind
of able to, you know, police ourselves so that, you know,
the department of justice didn't feel like they needed to get involved.
Right. Like, you know, okay. We'll make sure that, you know,
purity is really, really high. And, you know,
the people who are in our community are acting with integrity and,
you know, we've got kind of a, you know, reputation system for who's,
you know,
who's doing good work and who's kind of responsible to take the systems on
our own kind of, you know,
Sasha Shulgin had a, had a kind of a, basically a pilot's model,
a pilot's license where, you know, you kind of,
you kind of level up in your, you know,
your ability to navigate, you know,
extra dimensional spaces, if you will,
something like that would think would be really,
really beneficial to implement.
And I would, I would love to lean into people who are and support people who
are, you know, thinking along those lines.
Yeah, absolutely. Reflection.
Thank you for stepping up on the stage and as you know,
and keeping your anonymity and sharing your experience and concerns and what
you fear, what you hope for. We love that. And yeah,
thank you very much for,
for offering that and bringing your voice to the stage.
Um, would anyone else, uh, um, keeping an eye on time here,
we have about another less than 15 minutes here. Uh,
we don't necessarily need to use the full hour, but certainly if, uh,
others on the stage here want to, uh, others who are participating,
want to share their voice, share their experience, um,
please, uh, throw your, throw your hand up.
Hey guys. Uh, so maybe I don't know. Uh,
I got a question regarding, like,
I would like to, to, to test the water and see what you're,
what you're thinking about raising money for the Dow. Um,
and you know, and, and, and what, what can we do,
what can we do with the money? I mean, maybe it's obvious,
but how can we raise money and what, what are,
what will be the benefit for people that are contributing money to,
to the Dow? If you have some sort of thinking about it already?
Um, I don't have an answer yet. He,
there's some conversations internally about trying to figure out, um,
you know, there's, there's a few different models,
which does can raise money and none of them are perfect. Um, you know,
there's historically there's been kind of the NFT, the,
the NFT drop and we know put shell out 5,000 NFTs.
I don't think that's values aligned for us. Um,
you know,
there's a lot of institutional investors that are interested in having
conversations with us and putting some, bringing some money in. Um,
you know, we're trying to figure out how do we,
how do we structure that in a way that is both values aligned with the
community and not in violation of, you know, international securities laws.
Um, so it's, it's not a,
not an easy thing to structure. Um, you know,
especially because, especially because psychedelic.
So we're just locking up for a second. Um,
so the answer is I'm not,
I'm not sure yet where I think we'll come out with an announcement here,
hopefully in the next couple of weeks,
we've got a lot of internal meetings about this on the schedule. Um,
so hopefully we'll have something that's much more clear in the near future.
Matt, do you want to try and clarify that mud at all? I mean, I was,
that's the least helpful answer I could possibly give. So anything else?
Um, yeah, I think just, you know,
this is something we touched on a bit earlier. Um,
and, uh, this also kind of feeds into one of the reasons we're excited about,
um, the opportunity potentially of participating in the, in the,
in the seed club accelerator is, you know,
figuring out this piece of, um, you know,
we talked about earlier, right. Um,
doing something at the scale of like maps is, you know,
costs a hundred million dollars. And we've already said,
we don't want to be confined to that model, but also we also realized that if we
want to help, um, you know,
get research out about novel molecules, um, that, you know,
maybe it's like something like, you know,
DMT and cluster headaches or something that really people suffer under.
And it,
and it might not be a big enough market where someone's going to do research.
Like how do we actually get the research together and do it in a way? Um,
but then also make it so it's not the typical ball game where then the profits
just get monopolized or it gets super prohibitively expensive for people.
So that's just a long winded way of saying, you know,
like when you get down to the actual specific use cases, um,
and this is the stuff we're working through and discussing,
how do we, on the one hand,
raise enough capital to actually get the work done to make sure it's safe and
to make sure it's accessible and of the right quality, um,
and the right delivery mechanism, all that kind of stuff. Um,
while at the same time, not making,
making sure that, um,
investors have a unfair or, um,
or a monopoly on the actual IP or profits.
And I think these are,
this is the complexity of, of working in a,
the beauty and the complexity of working on something, uh,
like side out.
So this is why we're having all these discussions of figuring out, uh,
the governance, the tokenomics, um, how to build this right.
So it's sort of like, we don't really know yet.
And I think this is where we're talking about things like quadratic,
you know, voting and, and things like that.
I don't know if maybe I just muddied things up more, Adam.
I'm not sure.
I think that the summary is we're much more interested in building public goods
than, um, than pursuing the classic patent strategy.
Uh, you know, a lot, in a lot of ways side out came into existence as a
counterpoint to what compass and attire doing and some of the bad patents
that have, that have already muddied the landscape.
So we're, we're actively trying to innovate another solution.
We're actively seeking out conversations with, you know,
people in the indigenous community to try to find equitable ways to work
with them.
Um, um, we're actively trying to build intellectual property structures that
keep the community in the driver's seat of how that is managed, governed,
voted upon, you know, is it, you know, is it truly, is it true open source?
Is it what, you know, where does a public good, what is something that is like
open source stop and a public good start where it's owned by a large
collective, um, or governed by a large collective, but owned by everybody, you
know, these are all things that are not been possible practically prior to web
three, you know, the, there was no, there was no, functionally no way for an
international community to self-govern.
Like you just couldn't do it, right?
You were, if you could, if you, everyone was in the United States, you could set
up a co-op, right?
But if you had people in U S and Europe and Asia and Australia and Africa and
South America, there was no functional way to have any kind of like cohesive
government structure.
Like it was just, it was, you could do goodwill and that was it.
But now with, with DAOs and web three, we can actually, we can actually do this
kind of work without having to set up, you know, a battery of 20, you know,
international NGOs.
So it's really a unique moment in time to try and, to try and innovate on these
things.
But in a lot of ways, we're, we're having to design every layer of the stack as
we build it, because there are many things that you would think of our
assumptions when you start a business and when you start a nonprofit are not
clear, it could, cause it's totally open-ended.
Yeah.
So yeah, we're, we're, we're figuring it out as we, as we build it and you know,
taking some of the inheritance we have from being spun out of molecule in terms
of IP NFTs and seeing like, how can, you know, things like quadratic voting and IP
NFTs and other creative ways of, of kind of distributing and safeguarding the public
good and the public benefit of these, of these substances, these molecules, these
medicines in a way that's, that's meaningful, very much a work in progress.
Reflection, welcome back to the stage.
I see you requested to come back up.
Yeah.
I had a question.
Evan, how did you guys pick ETH as the blockchain to build on and are you worried at all with
the transfer between proof of work to proof of stake to who knows what the next step would
And did you consider any other blockchains, um, when you were starting this?
I think a lot of us on the team are, have a long history with Ethereum.
Um, and I, I, it seemed, you know, it's, it's clearly the leader among layer ones currently.
Um, so I think, you know, we have a, a pretty deep crypto savvy bench on our team.
Um, but I, I think, I think Ethereum is, has a very, very strong position among, among
cryptocurrencies right now.
Um, I'm, I'm, you know, I'm in chat in conversations with, uh, with a couple other with leadership
at a couple other layer ones.
Um, you know, I, I like their work.
I think there's, you know, some specialized use cases that are, that are certainly relevant.
Um, I'm not particularly concerned about the merge.
I think it's probably necessary and beneficial, um, you know, the way that, you know, the
exponential growth curve from an energy perspective makes cryptocurrencies difficult to kind of fathom
from a proof of work perspective.
If you just kind of continue to feed energy into them at this exponential rate, it's hard
for, it's hard for that to kind of align with, you know, regenerative economies, at least
until we have, you know, a really solid nuclear infrastructure.
Um, I would be concerned about something like, you know, sudden unexpected innovations in
quadratic, in, um, in quantum computing or something like that.
Um, but otherwise I think that anyway, I don't know if anyone else wants to pipe in on, jump
in on that, but that's kind of how I think about it.
Yeah.
I mean, um, I'm no expert by any means, but I would say that, yeah, I think that, uh, Ethereum,
um, is positioned in a way that, uh, and aligned in a way that that's what we want to pursue.
Um, but, uh, is there, is there another, is there another layer one or layer two that
you think we should, should be on our radar or it's kind of a, do you have thoughts on
this you want to jump in on?
I just was, I just proof of work and proof of stake just don't seem long-term are going
to work out.
Like you said, with the environment, energy, just the mechanism in general.
Um, so I was just curious to see if you guys, just your feelings on it in general and how
you picked ETH and what do you, what is your concern about proof of stake?
Cause I think proof of stake is a pretty significant innovation that, that actually increases the
decentralization of the architecture, you know, while also decreasing the, the energy requirements
of it.
Um, I just like proof of consensus.
There's just, I feel like more things coming out that might be a little bit better.
That's all.
Okay.
I've, you know, I'm, I'd be open to that.
Yeah.
I think once you, if psychedelics, psychedelics teach us anything, it's, you know, don't
identify too strongly with any particular, uh, idea or concept.
So, yeah.
Right.
I'm just, you know, all of this is new to all of us.
So it's just looking at all the different ones and seeing what might work best.
But at the same time, you guys are building and there's only certain places where you
can build and not have fear of building right now with legislation and no regulation, but
regulations coming.
So I was just curious.
Yeah.
I think, uh, your, your, your thoughts on, you know, to Adam's point, you know, keeping
an open perspective.
And if we have to pivot or use different tools, I guess the advantage for us is that, you know,
um, while we're doing, you know, developing things like IP NFT, um, um, I think a lot
of these, um, technologies are going to be able to become, um, multi-chain.
Um, and, um, if we have to, uh, you know, you know, we're not developing a, what separates
us is we're more of a, a community, uh, DAO and a decentralized science DAO where we're
not necessarily, we're not developing a protocol.
So I think that kind of protects us in a way that we can be a little bit more, um, agile
in terms of what, you know, what layers, what chains we use, um, and how we, how we, uh,
adapt what we develop.
Um, and, uh, I think, uh, Theo, you have your hand up?
Go ahead.
Why don't you close this out?
We're out of time.
Yeah.
I just wanted to, um, also jump in and like, I think also multi-chain could be the future.
We are all at the beginning of the decentralized DAO world and we are exploring like a whole
new chapter, um, from the beginning.
So there's a lot of learning, a lot of experiencing that's, that's just how life is.
And that's how this, this DAO world, um, is as well.
And, um, yeah, I, I just wanted to, because we have a call now, um, where we have to go.
So, so I have a call for at least, so I just wanted to thank the people who are tuned
in for the first time and, um, yeah, it's just, you know, for the contribution part,
just join the discord.
And, um, I also wanted to say that, um, it's, it's not like the hardest work on earth.
Like we, we are looking for people who can do marketing, who can edit, who can help on
the technical side.
So that's just something I wanted to drop out here.
Um, yeah, thank you.
Thank you, Theo.
And thank you to everyone else being at our inaugural, uh, community town hall.
Loved all the questions, love the participation.
Uh, keep eye out for some of the announcements in the near term here.
The website should be going live soon.
Um, and, uh, very much loving to have, uh, all of you more involved and, uh, engaged with,
uh, with SIDO.
Thank you so much.
Thanks everybody.
Talk to y'all soon.
Thanks.
Bye-bye.
